Clinical Trial Update: A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence trial comparing Norditropin and Genotropin (somatropin) in healthy adult subjects completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Disorders

Drugs mentioned

• GENOTROPIN (SOMATROPIN)
• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Disorder, Healthy | Phase 1 | Status: COMPLETED